AMICAS is a leader in radiology and medical image and information management solutions over the Internet.

Adlyfe Inc. develops innovative diagnostic technologies that can detect fatal brain diseases in the blood before symptoms occur.

Advanced BioHealing (ABH) is delivering the promise of regenerative medicine today.

AdvancePCS grew to become the nation’s largest independent provider of health improvement services.

ALDEA is developing novel enzyme activators to enhance the removal of toxic aldehydes, including those associated with the common flushing response to alcohol in persons of East Asian descent.

Alsius is the worldwide leader in core body temperature regulation technology.

Amicus is pioneering next-generation oral therapies for the management of human genetic diseases.

Apieron is developing a noninvasive monitor to measure exhaled nitric oxide for managing inflammation and controlling the underlying disease of asthma.

Axial Exchange is the open source solution to sharing health care information.

BiPar is developing a potential new class of tumor-selective drugs designed to meet the unmet needs of cancer patients.

Butterfly Health offers an innovative personal hygiene solution for the discreet protection of accidental bowel leakage.

Calibra is developing medical devices and technologies designed to make insulin therapy easier and more discreet.

Calixa is developing hospital-based antibiotics to treat infections resulting from resistant strains of bacteria.

Cell Pathways is a development-stage pharmaceutical company focused on novel medications to treat and prevent cancer and certain autoimmune diseases.

Centocor revolutionized the science of immunology and has been a leader in the field of cancer and immune-disorders for over 20 years.

Cerexa is an innovative biopharmaceutical company focused on developing therapies for the treatment of serious and life–threatening infections.

Chimerix is developing orally bioavailable antiviral therapies for unmet medical needs in immunocompromised patient populations, including transplant and oncology, HIV and HBV.

Civitas is focused on developing pulmonary delivery therapies uniquely able to deliver large and precise doses via a simple inhalational device to address significant unmet need medical needs. The company’s lead program is for patients with Parkinson’s disease.

Coapt’s revolutionary “soft tissue fixation technology” enables surgeons to reliably place and shape soft tissue during reconstructive procedures.

CoAxia is taking a pioneering approach to acute stroke treatment by developing a catheter that directs more blood flow to the brain through collateral vessels.

CombinatoRx is pioneering the new field of synergistic combination pharmaceuticals to provide a renewable and previously untapped source of novel drug candidates.

Cylex diagnostics have transformed the ability of doctors to measure immune system functioning.

CytomX is creating Probodies, which are masked antibodies that remain inert in healthy tissue but are activated in the disease microenvironment, improving the therapeutic index and utility of antibody drugs.

Data Sciences International is a pioneer in the field of wireless monitoring and the platform of choice for life science researchers worldwide.

Dermira is developing topical treatments for moderate to severe acne.

DexCom is tackling the diabetes epidemic by developing sensors that wirelessly transmit glucose readings to patients and their doctors.

DICOM Grid provides secure and simple access to medical images “in the cloud” reducing unnecessary and redundant tests, lowering radiation exposure to patients and making medical images immediately available to improve patient care.

Durata is a biopharmaceutical company pursuing late-stage clinical development of novel antibiotic programs.

Elevation Pharmaceuticals is focused on the development of new aerosol therapies for the treatment of COPD (chronic obstructive pulmonary disease).

EGS leverages the most current wisdom in gastroenterology and surgery in developing new transoral incisionless procedures and products to advance the state of the art in treating gastrointestinal diseases.

Eon Lab is a drug manufacturer that develops, manufactures, and markets a broad range of generic pharmaceutical products.

Esperion is a biopharmaceutical company focused on the discovery and development of therapies for the treatment of cardiovascular disease.

Personalized medicine through population genomics and informatics.

GenVec develops gene therapy products.

Immunicon is developing proprietary cell- and molecular-based human diagnostic products with an initial focus on cancer disease management.

IntelliCare is a healthcare contact center company that serves providers, payors, and clinical service providers.

Kalidex is developing next-generation, broad-spectrum antibiotics for the treatment of serious infections.

Labrys is developing a monoclonal antibody treatment for the prophylaxis of chronic migraine.

Liquidia Technologies Inc. is a nanotechnology company that designs and manufactures precisely engineered particles and films for a variety of life and material science applications.

Mariner Health is the leading provider of sub-acute medical services.

Marinus is creating a new class of neurologic drugs that may revolutionize the treatment of epilepsy in women and infants.

Matrix Pharmaceutical develops novel local and systemic cancer treatments that may improve or extend the lives of people living with cancer.

MID has developed the FloShield system, a franchise of products that substantially improve visualization during laparoscopic surgery.

Nellcor introduced the first clinically and commercially viable pulse oximeter and has grown to become the world’s foremost supplier of pulse oximetry.

Northstar Neuroscience is a medical device pioneering the development of cortical stimulation therapies to treat neurological injuries, disorders and diseases.

Novare Surgical Systems develops and markets RealHand, a platform technology representing an entirely new category of High Dexterity (HD) instruments for minimally invasive surgery.

Novira is an antiviral drug discovery company focused on the development of its capsid-targeting antivirals for the treatment of chronic hepatitis B (HBV) and HIV infections.

OraPharma is a specialty pharmaceutical company focused therapeutics for oral health.

ORTHOCON develops bioabsorbable drug delivery products for surgical patients with pain.

Pavad develops medical devices for the treatment of sleep apnea.

Peninsula Pharmaceuticals is developing new antibiotic medications to treat life-threatening infections.

Phylogix is an early-stage pharmaceutical company developing chemoprotectant compounds.

Pozen is a pharmaceutical company developing therapeutic advancements for treatment of acute migraine.

Praecis Pharmaceuticals is a biopharmaceutical company focused on Peptide-based therapeutics that have the potential to address unmet medical needs or improve existing therapies.

Relievant develops medical devices to address chronic back pain.

ReVision Optics (RVO) is improving eyesight though the development of a new technology aimed at the correction of presbyopia.

Revivant develops and markets proprietary technology to treat cardiac arrest.

Sopherion is a therapeutics platform company initially focused on cancer.

Spine Wave is committed to the development and delivery of high-quality innovative medical devices for the treatment of spinal disorders.

Theraclone Sciences harnesses the power of the human immune system to treat cancer and infectious diseases.

Tobira develops novel drugs to help in the treatment of HIV and AIDS.

Transcend is focused on treating glaucoma with a minimally invasive procedure that is effective, well-tolerated and safe.

VaxInnate invents vaccines that can be rapidly tailored to treat influenza and major pandemic illnesses.